微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 10.15% | -10.1% | 31.31% | 25/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 7.73% | -2.28% | 50.98% | 19/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 5.12% | -0.39% | -58% | 7/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 12.19% | -27.18% | 7.97% | 19/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 11.29% | -15.18% | 42.73% | 17/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 7.91% | -11.52% | 53.89% | 13/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 5.14% | -6.2% | -69.3% | 9/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 16.74% | 49.2% | 25.77% | 14/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 13.31% | 41.45% | 48.88% | 17/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.94% | 28.08% | 63.14% | 17/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.48% | 43.46% | -51.16% | 11/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 11.22% | -10.53% | 19.23% | 39/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.41% | -4.37% | 34.81% | 36/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.98% | -3.06% | 82.72% | 31/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.82% | 19.38% | -69.54% | 26/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 12.54% | 61.6% | 27.44% | 41/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 9.84% | 21.03% | 36.67% | 37/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 7.2% | 63.64% | 125% | 35/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.2% | 148.06% | -58.76% | 29/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 7.76% | 32.65% | -4.55% | 74/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 8.13% | 44.92% | 84.77% | 46/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.4% | 22.91% | 241.09% | 59/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.29% | 258.33% | -77.95% | 76/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.85% | -51.05% | 4.28% | 80/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.61% | -32.89% | 56.7% | 62/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.58% | -52.89% | 894.44% | 63/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.36% | -91.43% | -96.99% | 93/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 11.95% | -52.37% | 42.94% | 42/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.36% | 2% | 10% | 41/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 7.6% | 2% | 80.95% | 22/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 4.2% | -57.79% | -83.26% | 10/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 25.09% | -33.52% | -33.52% | 10/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2015-12-31 | 37.74% | -59.65% | 279.3% | 5/160 | 11.35% | 南新制药 | 81.7% | 行业排名> |
| 2015-03-31 | 9.95% | 2% | -89.36% | 3/160 | 2.41% | 德展健康 | 29.5% | 行业排名> |